Protein Kinases: What is the point of pseudokinases?
Protein kinases are enzymes that transfer a phosphate group from a molecule of ATP onto a protein or other substrate. This activity, known as ‘phosphorylation’, is important for a wide range of cellular processes. Over the last decade, as we have learned more about how these enzymes work, it has become clear that about 10% of the proteins that had been classified as protein kinases lack some of the key features that are required for kinase activity. These ‘inactive enzymes’, called pseudokinases, have evolved along side their enzymatically active counterparts. This implies that they still have a role to play in nature. Recent data suggest that one of these roles is to regulate the activity of other kinases (Rajakulendran and Sicheri, 2010; Shaw et al., 2014).
While most attention has focused on the role of protein phosphorylation inside cells, the large number of secreted proteins that are phosphorylated suggests that there are extracellular kinases. Jack Dixon of the University of California, San Diego (UCSD) and colleagues had previously carried out a search for secreted kinases and found a small family of ancient and atypical kinases that are responsible for a significant proportion of phosphorylation events that occur outside cells (Tagliabracci et al., 2012). Now, in eLife, Dixon and colleagues at UCSD—including Jixin Cui as the first author—provide further support for the idea that pseudokinases continue to carry out an important role, and provide clues to the evolutionary origin of pseudokinases.
Mutations in some these kinases are implicated in several disorders that affect bone and teeth (Simpson et al., 2007; O'Sullivan et al., 2011). For example, mutations in the gene for one of the family members, a kinase called Fam20C, results in the often fatal disorder known as Raine Syndrome. Mutations in the gene for the related Fam20A result in a distinct disorder known as Amelogenesis Imperfecta (which causes weakened and discolored teeth).
At first glance, the differences between these diseases could suggest that these two kinases might be regulated in different ways or target different substrates. But Dixon, Cui and colleagues report something more unexpected. Fam20A is a pseudokinase that controls the kinase activity of Fam20C (Cui et al., 2015).
On its own, Fam20C is a weak kinase. Fam20A, on the other hand, has no measurable kinase activity (even though it can bind ATP); and Dixon, Cui and colleagues explain why Fam20A is a pseudokinase rather than a true kinase. One of the most conserved features in all active kinases is a salt-bridge that forms between a conserved glutamic acid and a lysine. This glutamic acid is missing in Fam20A, which contains a glutamine in its place instead. Notably, this glutamine has also been conserved in Fam20A throughout evolution. When Dixon, Cui and colleagues replaced the glutamic acid in the kinase Fam20C with a glutamine, it significantly reduced the enzyme's activity. Moreover, swapping the glutamine in Fam20A for a glutamic acid turned this pseudokinase into an active kinase.
Dixon, Cui and colleagues then removed the gene for Fam20A in cells and found that the phosphorylation of tooth enamel proteins was significantly diminished. This was the case even through the Fam20C kinase was still present. Deletion of the gene for Fam20C completely abolished enamel protein phosphorylation. Together these findings suggested that the full kinase activity of Fam20C requires Fam20A. In vitro studies then confirmed that the addition of both the kinase and the psuedokinase are required for optimal kinase activity. Both Fam20A and Fam20C can each bind to themselves to form homodimers in solution. They can also bind to each other to form heterodimers. It is likely that the active form of the enzyme is a four-subunit complex as experiments showed that a mixture of Fam20A and Fam20C was a tetramer.
The exact mechanism by which Fam20A promotes the kinase activity of Fam20C is not yet clear. The interactive surfaces seen in the crystal structure of Fam20C could provide clues (Figure 1; Xiao et al., 2013), but a three-dimensional structure of the Fam20C/Fam20A heterodimer will be required for us to understand why it is strongly active while the Fam20C homodimer is not.
Work on other pseudokinase–kinase pairs suggests that the role of pseudokinase binding is to change the shape of the bona fide kinase in the pair into its active conformation (Jura et al., 2009; Zeqiraj et al., 2009; Hu et al., 2013). This kind of regulation is known as ‘allosteric activation’. In the classical model of kinase activation, phosphorylation of a part of a protein kinase called the activation loop triggers its active conformation (Kornev et al., 2008). The fact that Fam20C kinase does not have an activation loop that can be phosphorylated suggests that it is only regulated by its interaction with Fam20A.
The findings of Dixon, Cui and colleagues provide new insights into the evolutionary origin of pseudokinases. While Fam20C had weak kinase activity by itself in vitro, it was only after it was mixed with Fam20A that its true kinase activity was revealed. Fam20A and Fam20C are ancient kinases related to kinases in bacteria and slime molds. The fact that they don't use activation loop phosphorylation for regulation suggests that allosteric regulation (by pseudokinase/kinase heterodimerization) may be one of the earliest methods of kinase regulation. Only later, when the role of the activation loops evolved, did cross-phosphorylation (so-called ‘trans-phosphorylation’) become the dominant mechanism of activation. However, the continued presence of so many pseudokinases in modern organisms suggests that allosteric activation is still an important way that kinases are regulated. In addition, the existence of ‘inactive’ versions of other enzymes, like pseudophosphatases, suggests that dimerization and allosteric regulation could play a significant role in regulation of other enzymatic activities.
References
-
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3Proceedings of the National Academy of Sciences of USA 106:21608–21613.https://doi.org/10.1073/pnas.0912101106
-
A helix scaffold for the assembly of active protein kinasesProceedings of the National Academy of Sciences of USA 105:14377–14382.https://doi.org/10.1073/pnas.0807988105
-
Whole-Exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndromeAmerican Journal of Human Genetics 88:616–620.https://doi.org/10.1016/j.ajhg.2011.04.005
-
Kinases and pseudokinases: lessons from RAFMolecular and Cellular Biology 34:1538–1546.https://doi.org/10.1128/MCB.00057-14
-
Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine Syndrome), highlighting a crucial molecule in bone developmentAmerican Journal of Human Genetics 81:906–912.https://doi.org/10.1086/522240
-
Crystal structure of the Golgi casein kinaseProceedings of the National Academy of Sciences of USA 110:10574–10579.https://doi.org/10.1073/pnas.1309211110
Article and author information
Author details
Publication history
Copyright
© 2015, Raju and Shaw
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,517
- views
-
- 311
- downloads
-
- 7
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
In response to an ever-increasing demand of new small molecules therapeutics, numerous chemical and genetic tools have been developed to interrogate compound mechanism of action. Owing to its ability to approximate compound-dependent changes in thermal stability, the proteome-wide thermal shift assay has emerged as a powerful tool in this arsenal. The most recent iterations have drastically improved the overall efficiency of these assays, providing an opportunity to screen compounds at a previously unprecedented rate. Taking advantage of this advance, we quantified more than one million thermal stability measurements in response to multiple classes of therapeutic and tool compounds (96 compounds in living cells and 70 compounds in lysates). When interrogating the dataset as a whole, approximately 80% of compounds (with quantifiable targets) caused a significant change in the thermal stability of an annotated target. There was also a wealth of evidence portending off-target engagement despite the extensive use of the compounds in the laboratory and/or clinic. Finally, the combined application of cell- and lysate-based assays, aided in the classification of primary (direct ligand binding) and secondary (indirect) changes in thermal stability. Overall, this study highlights the value of these assays in the drug development process by affording an unbiased and reliable assessment of compound mechanism of action.
-
- Biochemistry and Chemical Biology
The intestinal absorption of essential nutrients, especially those not readily biosynthesized, is a critical physiological process for maintaining homeostasis. Numerous studies have indicated that intestinal absorption is mediated by various membrane transporters. Citrate, a crucial bioactive compound produced as an intermediate in the Krebs cycle, is absorbed in the small intestine through carrier-mediated systems because of its high hydrophilicity. While the luminal absorption of citrate is mediated by Na+-dicarboxylate cotransporter 1 (NaDC1/SLC13A2), the mechanism governing the release of the transported citrate into the bloodstream remains unknown. Here, we explored the transporters responsible for intestinal citrate absorption at the basolateral membrane, focusing on highly expressed orphan transporters in the small intestine as candidates. Consequently, SLC35G1, originally identified as a partner of stromal interaction molecule 1, a cell surface transmembrane glycoprotein, was found to play a role in the intestinal absorption of citrate at the basolateral membrane. Furthermore, our results revealed that SLC35G1-mediated citrate transport was diminished by chloride ions at physiologically relevant extracellular concentrations. This suggests that SLC35G1, to our best knowledge, is the first transporter identified to be extremely sensitive to chloride ions among those functioning on the basolateral membrane of intestinal epithelial cells. This study provides valuable insights into the intestinal absorption of citrate and significantly contributes to elucidating the poorly understood molecular basis of the intestinal absorption system.